| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |